Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease

被引:1770
作者
Berger, EA [1 ]
Murphy, PM
Farber, JM
机构
[1] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[3] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
关键词
AIDS; genetics; G protein-coupled receptors; pathogenesis; therapeutics;
D O I
10.1146/annurev.immunol.17.1.657
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to CD4, the human immunodeficiency virus (HIV) requires a coreceptor for entry into target cells. The chemokine receptors CXCR4 and CCR5, members of the G protein-coupled receptor superfamily, have been identified as the principal coreceptors for T cell line-tropic and macrophage-tropic HIV-1 isolates, respectively. The updated coreceptor repertoire includes numerous members, mostly chemokine receptors and related orphans. These discoveries provide a new framework for understanding critical features of the basic biology of HIV-1, including the selective tropism of individual viral variants for different CD4(+) target cells and the membrane fusion mechanism governing virus entry. The coreceptors also provide molecular perspectives on central puzzles of HIV-1 disease, including the selective transmission of macrophage-tropic variants, the appearance of T cell line-tropic variants in many infected persons during progression to AIDS, and differing susceptibilities of individuals to infection and disease progression. Genetic findings have yielded major insights into the in vivo roles of individual coreceptors and their ligands; of particular importance is the discovery of an inactivating mutation in the CCR5 gene which, in homozygous form, confers strong resistance to HIV-1 infection. Beyond providing new perspectives on fundamental aspects of HIV-1 transmission and pathogenesis, the coreceptors suggest new avenues for developing novel therapeutic and preventative strategies to combat the AIDS epidemic.
引用
收藏
页码:657 / 700
页数:44
相关论文
共 235 条
  • [141] CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
    Naif, HM
    Li, S
    Alali, M
    Sloane, A
    Wu, LJ
    Kelly, M
    Lynch, G
    Lloyd, A
    Cunningham, AL
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (01) : 830 - 836
  • [142] Napolitano M, 1996, J IMMUNOL, V157, P2759
  • [143] Nishiyama Y, 1997, CHEM PHARM BULL, V45, P2125, DOI 10.1248/cpb.45.2125
  • [144] The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
    Oberlin, E
    Amara, A
    Bachelerie, F
    Bessia, C
    Virelizier, JL
    ArenzanaSeisdedos, F
    Schwartz, O
    Heard, JM
    ClarkLewis, I
    Legler, DF
    Loetscher, M
    Baggiolini, M
    Moser, B
    [J]. NATURE, 1996, 382 (6594) : 833 - 835
  • [145] HIV-1 infection in a man homozygous for CCR5 Delta 32
    OBrien, TR
    Winkler, C
    Dean, M
    Nelson, JAE
    Carrington, M
    Michael, NL
    White, GC
    [J]. LANCET, 1997, 349 (9060) : 1219 - 1219
  • [146] Oravecz T, 1997, J IMMUNOL, V159, P4587
  • [147] Ostrowski MA, 1998, J IMMUNOL, V161, P3195
  • [148] The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into GD4-positive cells
    Owman, C
    Garzino-Demo, A
    Cocchi, F
    Popovic, M
    Sabirsh, A
    Gallo, RC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9530 - 9534
  • [149] Inhibition of HIV-1 infection by the beta-chemokine MDC
    Pal, R
    GarzinoDemo, A
    Markham, PD
    Burns, J
    Brown, M
    Gallo, RC
    DeVico, AL
    [J]. SCIENCE, 1997, 278 (5338) : 695 - 698
  • [150] Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency viruses
    Parolin, C
    Borsetti, A
    Choe, HY
    Farzan, M
    Kolchinsky, P
    Heesen, M
    Ma, Q
    Gerard, C
    Palú, G
    Dorf, ME
    Springer, T
    Sodroski, J
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 1652 - 1656